3-Formylchromone based topoisomerase IIα inhibitors: discovery of potent leads
- 3 July 2013
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 4 (9) , 1257-1266
Abstract
Substituted 3-formylchromones were synthesized and evaluated as inhibitors of the human DNA topoisomerase IIα (hTopo-IIα) enzyme. The results of the decatenation, relaxation and DNA intercalation assays revealed that the compounds (11b, 12a, 12b, 12d, 12e, 13a and 13b) exhibited potent inhibitory activity against the hTopo-IIα enzyme, and are nonintercalating agents. These compounds also possess significant in vitro cytotoxicity (LC50 ranges from 0.5–8.6 μM) against prostate (PC-3) cancerous cell line as seen in comparison to the standard drug etoposide. To further probe the plausible mode of action of 3-formylchromone derivatives, molecular docking studies have also been carried out, which showed that the compounds under investigation fitted well in the ATP binding pocket of hTopo-IIα enzyme with good docking scores and form nonbonding interactions with the crucial residues of the catalytic site.Keywords
This publication has 35 references indexed in Scilit:
- Synthesis and Biological Activities of TopopyronesJournal of Natural Products, 2012
- N-Fused Imidazoles As Novel Anticancer Agents That Inhibit Catalytic Activity of Topoisomerase IIα and Induce Apoptosis in G1/S PhaseJournal of Medicinal Chemistry, 2011
- DNA topoisomerase II, genotoxicity, and cancerMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2007
- Topoisomerase I inhibitors: camptothecins and beyondNature Reviews Cancer, 2006
- Design, synthesis, and evaluation of novel 6-chloro-/fluorochromone derivatives as potential topoisomerase inhibitor anticancer agentsBioorganic & Medicinal Chemistry Letters, 2006
- Nucleotide-dependent Domain Movement in the ATPase Domain of a Human Type IIA DNA TopoisomeraseJournal of Biological Chemistry, 2005
- A Human Topoisomerase IIα Heterodimer with Only One ATP Binding Site Can Go through Successive Catalytic CyclesJournal of Biological Chemistry, 2003
- Human small cell lung cancer NYH cells resistant to the bisdioxopiperazine ICRF‐187 exhibit a functional dominant Tyr165Ser mutation in the Walker A ATP binding site of topoisomerase IIαFEBS Letters, 2002
- A Fast Flexible Docking Method using an Incremental Construction AlgorithmJournal of Molecular Biology, 1996
- Harmonic Vibrational Frequencies: An Evaluation of Hartree−Fock, Møller−Plesset, Quadratic Configuration Interaction, Density Functional Theory, and Semiempirical Scale FactorsThe Journal of Physical Chemistry, 1996